Docetaxel

NDC 43066-010 · Baxter Healthcare Corporation

Generic namedocetaxel

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DOCETAXEL

Strength10 mg/mL

Pharmacologic classMicrotubule Inhibition [PE], Microtubule Inhibitor [EPC]

Marketing categoryNDA

Packages

43066-010-01 — 1 VIAL, MULTI-DOSE in 1 CARTON (43066-010-01) / 16 mL in 1 VIAL, MULTI-DOSE

Billed under HCPCS

J9232 — Injection, docetaxel (hospira), not therapeutically equivalent to j9171, 1 mg Medicare Part B payment limit (ASP + 6%): $0.51

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0409-4235 — DOCETAXEL, 0409-5068 — DOCETAXEL, 0955-1020 — Docetaxel, 0955-1021 — Docetaxel, 0955-1022 — Docetaxel, 23155-903 — Docetaxel, 23155-904 — Docetaxel, 23155-905 — Docetaxel, 43066-001 — docetaxel, 43066-006 — docetaxel, 43598-258 — Docetaxel, 43598-259 — Docetaxel, 43598-389 — Docetaxel, 43598-610 — Docetaxel, 43598-611 — Docetaxel, 45963-734 — Docetaxel, 45963-765 — Docetaxel, 57884-3041 — Docetaxel, 57884-3042 — Docetaxel, 57884-3043 — Docetaxel, +13 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q4 (October 2026 release). All data sources · How to read the labels

Current data releases:ICD-10-CM FY2027 · ICD-10-PCS FY2027 · HCPCS October 2026 · MS-DRG v44 · Medicare Code Editor v44.0 · NCCI PTP Q4 2026 · MUE Q4 2026 · NCD code lists 2026-01 · LCD export September 28, 2026 · All releases and sources